BlackRock Inc. - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 85 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2022. The put-call ratio across all filers is 5.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$435,445
-4.1%
537,587
-17.1%
0.00%
Q1 2023$453,962
-0.4%
648,517
+0.5%
0.00%
Q4 2022$455,580
-52.1%
645,298
+3.2%
0.00%
Q3 2022$951,000
+69.2%
625,567
+10.4%
0.00%
Q2 2022$562,000
-83.1%
566,482
-75.4%
0.00%
Q1 2022$3,318,000
-73.0%
2,304,116
-2.2%
0.00%
Q4 2021$12,295,000
-9.5%
2,355,162
+1.1%
0.00%
Q3 2021$13,587,000
-27.6%
2,330,444
+0.1%
0.00%
-100.0%
Q2 2021$18,760,000
-4.9%
2,327,793
-1.8%
0.00%0.0%
Q1 2021$19,728,000
+12.9%
2,370,986
+2.9%
0.00%0.0%
Q4 2020$17,471,000
-26.6%
2,304,788
+3.2%
0.00%0.0%
Q3 2020$23,795,000
-29.5%
2,232,349
+0.3%
0.00%0.0%
Q2 2020$33,752,000
+96.1%
2,226,250
+7.8%
0.00%0.0%
Q1 2020$17,208,000
-50.4%
2,065,680
+0.6%
0.00%0.0%
Q4 2019$34,699,000
-8.1%
2,053,162
+1.0%
0.00%
-50.0%
Q3 2019$37,750,000
-17.7%
2,032,816
+1.4%
0.00%0.0%
Q2 2019$45,865,000
+25.6%
2,004,650
+15.4%
0.00%0.0%
Q1 2019$36,510,000
+77.7%
1,736,946
-2.8%
0.00%
+100.0%
Q4 2018$20,542,000
-49.9%
1,786,217
+0.0%
0.00%
-50.0%
Q3 2018$40,983,000
+5.0%
1,785,849
+2.0%
0.00%0.0%
Q2 2018$39,046,000
+1.7%
1,750,891
+4.2%
0.00%0.0%
Q1 2018$38,397,000
-12.9%
1,680,444
-0.2%
0.00%0.0%
Q4 2017$44,095,000
+18.0%
1,683,028
+1.1%
0.00%0.0%
Q3 2017$37,383,000
-11.4%
1,665,180
+7.9%
0.00%0.0%
Q2 2017$42,196,000
+19.5%
1,542,833
+5.7%
0.00%0.0%
Q1 2017$35,310,000
+100785.7%
1,459,052
+85075.2%
0.00%
Q4 2016$35,000
-35.2%
1,713
-13.1%
0.00%
Q3 2016$54,000
+107.7%
1,972
+10.8%
0.00%
Q2 2016$26,000
+30.0%
1,780
+27.8%
0.00%
Q1 2016$20,000
+66.7%
1,393
+156.1%
0.00%
Q4 2015$12,000
+33.3%
5440.0%0.00%
Q3 2015$9,000
-35.7%
5440.0%0.00%
Q2 2015$14,000
+16.7%
5440.0%0.00%
Q1 2015$12,000
+20.0%
5440.0%0.00%
Q4 2014$10,000
-16.7%
5440.0%0.00%
Q3 2014$12,000
-14.3%
5440.0%0.00%
Q2 2014$14,0005440.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders